Brain Network Changes Accompanying and Predicting Responses to Pharmacotherapy in OCD
Mental Health & Behavioral Research
What is the purpose of this trial?
The proposed randomized, double-blind research study will use functional magnetic resonance neuroimaging using state-of-the-art HCP acquisition protocols and analytic pipelines, to identify predictors and correlates of response to an accepted first-line pharmacological treatment for obsessive-compulsive disorder.
- Trial withYale University School of Medicine
- Start Date07/27/2018
- End Date07/31/2024
- Last Updated11/11/2022
- Study HIC#2000023688